Login / Signup

Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?

Yong WangQing MaoXiangdong Zhou
Published in: Proceedings of the National Academy of Sciences of the United States of America (2020)
Keyphrases
  • rheumatoid arthritis
  • sars cov
  • juvenile idiopathic arthritis
  • rheumatoid arthritis patients
  • disease activity
  • adverse drug
  • emergency department
  • electronic health record